Cigna Dupilumab (Dupixent) prior authorization requirements (2026)

What Cigna generally requires to approve Dupilumab (Dupixent) (CPT J0517), for Commercial (pharmacy benefit; J0517 medical benefit) plans. Yes. Cigna generally requires prior authorization for Dupilumab (Dupixent) (CPT J0517).

General reference compiled from public sources, last verified 2026-06-17. This is not a coverage determination or medical advice. Always confirm current requirements with Cigna before submitting.

Medical-necessity criteria Cigna generally applies

Prior authorization required (usually adjudicated under the pharmacy benefit; HCPCS J0517 applies under the medical benefit). ATOPIC DERMATITIS (prescribed by/with an allergist, immunologist, or dermatologist): age 6 months or older AND either atopic dermatitis involving at least 10% of body surface area, OR moderate-to-severe hand and/or foot atopic dermatitis in a patient 12 years or older; AND a trial of at least one medium-potency-or-higher prescription topical corticosteroid applied daily for at least 28 consecutive days with documented inadequate efficacy. Initial approval 4 months; continuation 1 year with documented response.

Diagnoses that commonly support medical necessity

ICD-10-CM diagnoses frequently associated with medical necessity for Dupilumab (Dupixent). Confirm the covered diagnosis list against the current Cigna policy.

L20.9Atopic dermatitis, unspecifiedL20.89Other atopic dermatitis

Commonly required documentation

  • Diagnosis and severity (BSA or hand/foot involvement)
  • documented 28-day topical corticosteroid trial
  • specialist prescriber.

How to submit

Source

Source: Cigna Coverage Policy cnf_420 Dupixent (review 2026-04-01). Requires one topical-class failure. J0517 is the medical-benefit code. Last verified 2026-06-17.

Frequently asked questions

Does Cigna require prior authorization for Dupilumab (Dupixent)?

Yes. Cigna generally requires prior authorization for Dupilumab (Dupixent) (CPT J0517).

What does Cigna require to approve Dupilumab (Dupixent)?

Prior authorization required (usually adjudicated under the pharmacy benefit; HCPCS J0517 applies under the medical benefit). ATOPIC DERMATITIS (prescribed by/with an allergist, immunologist, or dermatologist): age 6 months or older AND either atopic dermatitis involving at least 10% of body surface area, OR moderate-to-severe hand and/or foot atopic dermatitis in a patient 12 years or older; AND … Always confirm against the current Cigna policy.

How long does a Cigna prior authorization take?

Turnaround varies by plan and submission method. Check the Cigna portal for current timeframes.

Submitting Dupilumab (Dupixent) to Cigna?

Praxigen checks your clinical note against these criteria before you submit and drafts a policy-cited appeal if it is denied. You review and submit; nothing is sent automatically.

How Praxigen worksBook a demo

Other Cigna prior authorization requirements

ACL ReconstructionAnterior Cervical Discectomy and FusionArthroscopic Hip Surgery for Impingement Syndrome Including Labral RepairAutologous Chondrocyte ImplantationBunionectomy (Hallux Valgus Correction)Endovenous Ablation (Varicose Veins)Hip OsteotomyInfliximab (Remicade & Biosimilars)Knee ArthroscopyKnee MeniscectomyLumbar Spinal FusionOutpatient Physical Therapy

Related guides

Why was my prior authorization denied? Top reasons and how to fix eachHow to write a prior authorization appeal that cites policy